Stardust Power Breaks Ground on One of the Largest U.S. Battery-Grade Lithium Refineries

Enters Construction Phase, Deepening Commitment to Strengthening U.S. Leadership and Creating New Manufacturing Jobs for Oklahoma’s Growing Economic Success Building a Stronger Economy As the project enters its construction phase, the focus is on strengthening U.S. leadership in the manufacturing industry. This initiative not only aims to create new manufacturing jobs for Oklahoma, but also…

Read More

“Uncovering the Potential of British American Tobacco: Is This Ultra-High Yield Stock a Smart Investment for 2025?”

High-Yield Dividend Stocks: A Double-Edged Sword for Investors High-yield dividend stocks present an intriguing paradox for investors. While historical data shows they can outperform the S&P 500 over multidecade periods when dividends are reinvested, many high-yielding stocks struggle to match market returns over the short term. The Appeal of High-Yield Dividend Stocks Investors are often…

Read More

“Uncovering the Truth: BioAge Labs Inc. Faces Securities Fraud Class Action Lawsuit – Act Now to Protect Your Rights with Levi and Korsinsky!”

New York City, NY – Recovering Losses on BioAge Labs, Inc. (NASDAQ:BIOA) Investment Are you considering a potential recovery for your losses on BioAge Labs, Inc. (NASDAQ:BIOA) investment? January 23, 2025/ACCESS Newswire – If you suffered a loss on your BioAge Labs, Inc. investment and want to learn about a potential recovery under the federal…

Read More

“Attention Investors: Protect Your Rights in Capri Holdings Limited – Contact Levi and Korsinsky Before February 21, 2025!”

High-Quality Fashion Brand Capri Holdings Faces Legal Troubles Investors Seek Recovery Following Loss on Capri Holdings Limited In recent news, it was reported that Capri Holdings Limited (NYSE:CPRI) is facing potential legal issues under the federal securities laws. Investors who suffered losses on their investment in this high-end fashion brand are seeking information on how…

Read More

InflaRx to Participate in Guggenheim SMID Cap Biotech Conference

InflaRx N.V. Participating in Guggenheim SMID Cap Biotech Conference JENA, Germany, Jan. 23, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company specializing in anti-inflammatory therapeutics through the targeting of the complement system, has announced its participation in the upcoming Guggenheim SMID Cap Biotech Conference. The conference is scheduled to take place on…

Read More